Laxmi Dental Ltd

Laxmi Dental Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Laxmi Dental Ltd

₹ 395 -1.35%
30 Apr 10:20 a.m.
laxmidentallimited.com BSE: 544339 NSE: LAXMIDENTL
About

Incorporated in 2004, Laxmi Dental is an integrated dental products company offering a comprehensive portfolio of Dental Products[1]

Key Points

Leading Dental Company[1]
Laxmi Dental is the only end-to-end integrated dental products company in India. Based on FY23 revenue & PAT, the company is the largest and most profitable vertically integrated, indigenous B2B2C dental aligner solutions provider.

Website BSE NSE
  • Market Cap ₹ 2,171 Cr.
  • Current Price ₹ 395
  • High / Low ₹ 584 / 308
  • Stock P/E 154
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE 8.98 %
  • ROE 35.2 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -44.9%
  • Company has a low return on equity of 9.17% over last 3 years.
  • Earnings include an other income of Rs.14.4 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE IPO

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2023 Sep 2024 Dec 2024
34.92 41.99 43.35
33.81 37.22 37.77
Operating Profit 1.11 4.77 5.58
OPM % 3.18% 11.36% 12.87%
3.07 2.92 2.04
Interest 1.10 0.86 1.01
Depreciation 2.49 2.13 2.67
Profit before tax 0.59 4.70 3.94
Tax % -200.00% 19.15% 18.53%
1.76 3.80 3.21
EPS in Rs 57.16 1.37 0.62
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
112 63 113 126 139
110 59 109 119 128
Operating Profit 3 4 4 6 12
OPM % 3% 7% 3% 5% 8%
1 0 4 8 14
Interest 3 3 3 4 5
Depreciation 6 6 7 9 9
Profit before tax -5 -4 -2 1 12
Tax % 5% 9% 116% 0% -85%
-5 -4 -4 1 23
EPS in Rs -155.57 -140.95 -144.20 46.12 737.58
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 30%
TTM: 11%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 93%
TTM: 2418%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 9%
Last Year: 35%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 0.31 0.31 0.31 0.31 0.31
Reserves 44 40 36 28 51
36 36 37 42 50
28 29 33 37 31
Total Liabilities 109 105 106 108 132
38 41 32 35 33
CWIP 0 0 0 0 0
Investments 16 16 17 14 14
54 48 57 59 85
Total Assets 109 105 106 108 132

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
10 10 -1 10 5
-15 -9 2 -6 -6
6 -1 -1 -1 -2
Net Cash Flow 0 1 -1 3 -3

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 90 95 73 85 88
Inventory Days 189 377 207 162 167
Days Payable 184 310 156 151 82
Cash Conversion Cycle 95 162 123 95 172
Working Capital Days 68 79 74 76 121
ROCE % 0% 1% 6% 9%

Shareholding Pattern

Numbers in percentages

Mar 2025
41.70%
34.24%
12.86%
11.19%
No. of Shareholders 29,482

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.

DRHP

Concalls